The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)
2: Our ability to supply and a variety of flexible solutions, is very suitable for all kinds of needs of buyers
It all boils down to the need of the patient, even when the injectables are good but oral supplements are also acceptable depending on the needs of the patient
clinicians must account for dermal absorption, especially when large surface areas are treated
Thymosin 4: structure, function, and biological properties supporting current and future clinical applications
Ann Clin Lab Sci, 45 (4), 426-432